Medicine
Nymalize 30 mg/5 mL oral solution
Nymalize 30 mg/5 mL oral solution is a prescription medicine containing Nimodipine for oral use, marketed by Azurity Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not refrigerate. Store between 20ºC to 25ºC (68ºF to 77ºF), excursions…
Key facts
- Active ingredient (INN)
- Nimodipine
- Brand
- Nymalize
- Strength
- 30 mg/5 mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 12 package, 12 blister pack, 237 mL and 1 more
- Marketing authorisation holder
- Azurity Pharmaceuticals
- Manufacturer
- Azurity Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Do not refrigerate. Store between 20ºC to 25ºC (68ºF to 77ºF), excursions permitted to 15ºC to 30ºC (59ºF to 86ºF). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C08CA06 Nimodipine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 May 2020
- Identifiers
- RxCUI 2361311, 2361313DailyMed set ID e660fa26-b5c4-4d6d-8887-9e22b6666a10NDC 24338-260, 24338-230Application NDA203340
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 package in 1 carton / 1 syringe, plastic in 1 package / 5 mL in 1 syringe, plastic | 24338-230-12 | Azurity Pharmaceuticals | 4 May 2020 |
| 12 blister pack in 1 carton / 1 syringe, plastic in 1 blister pack / 5 mL in 1 syringe, plastic | 24338-230-30 | Azurity Pharmaceuticals | 30 September 2024 |
| 237 mL in 1 bottle | 24338-260-08 | Azurity Pharmaceuticals | 13 July 2021 |
| 12 package in 1 carton / 1 syringe, plastic in 1 package / 10 mL in 1 syringe, plastic | 24338-260-12 | Azurity Pharmaceuticals | 4 May 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 December 1988 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Nimodipine
Clinical summary
Nimodipine is a dihydropyridine calcium channel blocker. It is available as oral solution and capsules. MedsAcross supplies Nimodipine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NimodipineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Nymalize prescribing information (Azurity Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Nymalize 30 mg/5 mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.